10 Hottest Stocks to Watch on Wednesday
The US stock market is in the green today, with investors absorbing the earnings results of some notable companies.
Sierra Oncology Inc. (SRRA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 0 | $0 | -100% | 0% |
| 2. | GAMCO Investors Mario Gabelli | 0 | $0 | -100% | 0% |
| 3. | Pentwater Capital Management Matthew Halbower | 0 | $0 | -100% | 0% |
| 4. | Dorset Management David M. Knott | 0 | $0 | -100% | 0% |
| 5. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.00 | 175,000 | Large Shareholder | 175,000 | 2022-02-02 | Filing | |
| $27.00 | 175,000 | Large Shareholder, Director | 175,000 | 2022-02-02 | Filing | |
| $27.00 | 150,000 | Director | 1,314,127 | 2022-01-31 | Filing | |
| $27.00 | 150,000 | Large Shareholder | 1,314,127 | 2022-01-31 | Filing | |
| $27.00 | 800,000 | Large Shareholder | 2,735,853 | 2022-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.25 | 6,347 | Officer | 0 | 2022-04-06 | Filing | |
| $37.09 | 100 | Officer | 0 | 2022-04-05 | Filing | |
| $35.14 | 2,000 | Officer | 0 | 2022-04-04 | Filing | |
| $37.05 | 100 | Officer | 0 | 2022-03-18 | Filing | |
| $37.06 | 3,453 | Officer | 0 | 2022-03-17 | Filing |
Institutional Investors' Holdings
News See All
Hedge Fund and Insider Trading News: Bill Ackman, Alden Global Capital, Portal Asset Management, Sterling Bancorp (STL), Sierra Oncology Inc (SRRA), and More
Investor Bill Ackman said the new omicron variant of the coronavirus could actually give U.S. stocks a boost if symptoms turn out to be less severe.
Is SRRA A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Sierra Oncology, Inc. (SRRA): Hedge Funds In Wait-and-See Mode
In this article you are going to find out whether hedge funds think Sierra Oncology, Inc. (NASDAQ:SRRA) is a good investment right now.
Here is What Hedge Funds Think About Sierra Oncology, Inc. (SRRA)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been More Bullish On Sierra Oncology, Inc. (SRRA)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
13G Filing: Perceptive Advisors and Sierra Oncology Inc. (SRRA)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...